CELLULAR AND MOLECULAR BASIS OF GAMMA/DELTA T CELL ANTIGEN RECOGNITION
Gamma/Delta T 细胞抗原识别的细胞和分子基础
基本信息
- 批准号:9101988
- 负责人:
- 金额:$ 23.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-03-15 至 2017-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAntigen ReceptorsAntigensBacterial InfectionsBacterial MeningitisBindingBiochemicalBiologicalCD8B1 geneCell physiologyCell surfaceCellsCharacteristicsDiseaseEpithelialEventGeneticGoalsHistocompatibility AntigensHumanImaging technologyImmuneImmunityImmunologic MonitoringIn VitroInfectionInfectious AgentInflammationInflammatoryInterferonsInterleukin-17InvadedKnowledgeLeadLigationLipidsLymphocyteMalariaMalignant NeoplasmsMediatingModalityMolecularMonitorMycobacterium InfectionsNeutrophil InfiltrationOrganismOutcomeParasitic infectionPathway interactionsPeptidesPropertyProteinsReceptor SignalingRecruitment ActivityRoleSignal TransductionSignaling MoleculeSiteStressStructureSurfaceT-LymphocyteTestingTherapeuticTransgenic MiceTuberculosisUncertaintyVirus DiseasesWorkabstractingadaptive immunitybasecytokinedesignexperiencefunctional outcomesimaging modalityimmune activationimmunological synapseimmunological synapse formationin vivo imagingkillingsmucosal siteneoplasticneutrophilpathogenperforinpreferencereceptorresponsespatiotemporalsubmicrontargeted treatmentvaccination strategy
项目摘要
PROJECT SUMMARY/ABSTRACT
Gamma/delta () T cells are specialized immune cells that are thought to be a first line of defense
against major infections. They are known to be activated early during infections such as tuberculosis, malaria,
and bacterial meningitis. T cells recognize and respond to infectious agents using a receptor (the antigen
receptor, or TCR) on their surface, which binds to parts of infecting organisms (antigens) or other molecules
on infected cells that indicate their presence. In addition to recognition of invading organisms by the TCR,
other `costimulatory' and `accessory' surface receptors cooperate to generate biochemical signals to activate
the cell. This results in the release of proteins that kill infected cells (eg. perforin), as well as soluble factors
(eg. cytokines IFN and IL-17) that attract other types of immune cells, such as neutrophils and conventional
T cells, to sites of infection and inflammation.
Surprisingly little is known about how the TCR, along with associated accessory and costimulatory
receptors, work to activate the cell. These molecular interactions, which together form the basis for antigen
recognition, is thought to take place at a specialized junction that forms between T cells and infected cells
known as the immunological synapse, but how it is organized and functions is unclear. It also seems that T
cells must recognize components of infecting organisms when they are bound to other `presenting' molecules
on the cell surface. However, the identity of these molecules and the strategies used by TCRs to recognize
them, remain obscure. These uncertainties about how T cells recognize and are activated by infections
present major impediments to their effective harnessing in treatments and vaccination strategies targeting
these diseases.
I aim to understand the molecular underpinnings of T cell function using advanced in vitro and in vivo
imaging technologies, to identify mechanisms of immune activation in these cells that are critical for their role in
responding to infections. This work will lead to a more detailed understanding of these medically relevant
immune cells, and may contribute to the design of strategies to enhance our immune defenses by boosting
T cell function.
项目概要/摘要
γ/δ () T 细胞是特殊的免疫细胞,被认为是第一道防线
已知它们在结核病、疟疾、
和细菌性脑膜炎 T 细胞使用受体( 抗原)识别感染因子并做出反应。
受体,或 TCR)位于其表面,与感染生物体的部分(抗原)或其他分子结合
除了通过 TCR 识别入侵生物体之外,
其他“共刺激”和“辅助”表面受体合作产生生化信号以激活
这导致细胞释放杀死受感染细胞的蛋白质(例如穿孔素)以及可溶性因子。
(例如细胞因子 IFN 和 IL-17)吸引其他类型的免疫细胞,例如中性粒细胞和常规细胞
T 细胞,到达感染和炎症部位。
令人惊讶的是,人们对 TCR 以及相关的辅助和共刺激如何发挥作用知之甚少。
这些分子相互作用共同构成了抗原的基础。
识别被认为发生在 T 细胞和感染细胞之间形成的特殊连接处
被称为免疫突触,但它的组织和功能似乎还不清楚。
当细胞与其他“呈递”分子结合时,细胞必须识别感染生物体的成分
然而,这些分子的身份以及 TCR 识别的策略。
关于 T 细胞如何识别感染并被感染激活的这些不确定性仍然不清楚。
对有效利用它们进行治疗和疫苗接种策略构成了主要障碍
这些疾病。
我的目标是利用先进的体外和体内技术来了解 T 细胞功能的分子基础
成像技术,以确定这些细胞中的免疫激活机制,这对于它们的作用至关重要
这项工作将有助于人们更详细地了解这些与医学相关的问题。
免疫细胞,并可能有助于设计通过增强 来增强我们的免疫防御的策略
T细胞功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kaushik Choudhuri其他文献
Kaushik Choudhuri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kaushik Choudhuri', 18)}}的其他基金
BIOPHYSICAL TUNING OF CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALING FOR SAFE AND EFFECTIVE T CELL IMMUNOTHERAPY
嵌合抗原受体 (CAR) 信号转导的生物物理调节以实现安全有效的 T 细胞免疫治疗
- 批准号:
10413245 - 财政年份:2021
- 资助金额:
$ 23.37万 - 项目类别:
BIOPHYSICAL TUNING OF CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALING FOR SAFE AND EFFECTIVE T CELL IMMUNOTHERAPY
嵌合抗原受体 (CAR) 信号转导的生物物理调节以实现安全有效的 T 细胞免疫治疗
- 批准号:
10284715 - 财政年份:2021
- 资助金额:
$ 23.37万 - 项目类别:
CELL BIOLOGY AND MOLECULAR MECHANISMS OF HUMAN GAMMA/DELTA T CELL ACTIVATION
人类伽马/德尔塔 T 细胞激活的细胞生物学和分子机制
- 批准号:
10166762 - 财政年份:2019
- 资助金额:
$ 23.37万 - 项目类别:
CELL BIOLOGY AND MOLECULAR MECHANISMS OF HUMAN GAMMA/DELTA T CELL ACTIVATION
人类伽马/德尔塔 T 细胞激活的细胞生物学和分子机制
- 批准号:
10625480 - 财政年份:2019
- 资助金额:
$ 23.37万 - 项目类别:
CELL BIOLOGY AND MOLECULAR MECHANISMS OF HUMAN GAMMA/DELTA T CELL ACTIVATION
人类伽马/德尔塔 T 细胞激活的细胞生物学和分子机制
- 批准号:
10407054 - 财政年份:2019
- 资助金额:
$ 23.37万 - 项目类别:
Cellular and Molecular Basis of Gamma/Delta T Cell Antigen Recognition
Gamma/Delta T 细胞抗原识别的细胞和分子基础
- 批准号:
8663991 - 财政年份:2013
- 资助金额:
$ 23.37万 - 项目类别:
CELLULAR AND MOLECULAR BASIS OF GAMMA/DELTA T CELL ANTIGEN RECOGNITION
Gamma/Delta T 细胞抗原识别的细胞和分子基础
- 批准号:
8300595 - 财政年份:2012
- 资助金额:
$ 23.37万 - 项目类别:
CELLULAR AND MOLECULAR BASIS OF GAMMA/DELTA T CELL ANTIGEN RECOGNITION
Gamma/Delta T 细胞抗原识别的细胞和分子基础
- 批准号:
9039860 - 财政年份:2012
- 资助金额:
$ 23.37万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
利用肝癌动物模型开展化学可控的在体基因编辑体系的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The role of complement in chronic neuroinflammation and cognitive decline after closed head brain injury
补体在闭合性脑损伤后慢性神经炎症和认知能力下降中的作用
- 批准号:
10641096 - 财政年份:2023
- 资助金额:
$ 23.37万 - 项目类别:
CAR-T cell treatment of CNS Autoimmunity
CAR-T细胞治疗中枢神经系统自身免疫
- 批准号:
10641913 - 财政年份:2022
- 资助金额:
$ 23.37万 - 项目类别:
Sexual dimorphism in antigen-independent angiogenesis inhibition of IgG1 antibodies
IgG1 抗体的抗原非依赖性血管生成抑制中的性别二态性
- 批准号:
10536062 - 财政年份:2022
- 资助金额:
$ 23.37万 - 项目类别:
BCCMA: Cartilage Repair Strategies to Alleviate Arthritis Pain (Care AP): Targeting Pattern-Recognition to Reduce Pain-Related Pathology in Osteoarthritis
BCCMA:缓解关节炎疼痛的软骨修复策略(Care AP):以模式识别为目标,减少骨关节炎中与疼痛相关的病理
- 批准号:
10620628 - 财政年份:2022
- 资助金额:
$ 23.37万 - 项目类别:
CAR-T cell treatment of CNS Autoimmunity
CAR-T细胞治疗中枢神经系统自身免疫
- 批准号:
10539779 - 财政年份:2022
- 资助金额:
$ 23.37万 - 项目类别: